Renal Cancer pp 271-282 | Cite as

Role of Lymphadenectomy

Chapter

Abstract

Surgical extirpation of regional lymph nodes in the treatment of renal cell carcinoma (RCC) is currently accepted as the most accurate staging procedure for the detection of lymph node invasion. However, the therapeutic benefit still remains controversial. The renal lymphatic drainage is unpredictable, and the extent of lymph node dissection (LND) is a matter of debate. Small lymph node metastases cannot be visualised by the currently available imaging techniques. The European Organization for Research and Treatment of Cancer (EORTC) trial number 30881 shows that performing LND in patients with T1–T2 clinically node-negative (N0) RCC offers limited staging information and no benefit in terms of decreasing disease recurrence or improving survival. Numerous retrospective studies show that high-risk patients with advanced or metastatic disease should undergo LND because they may benefit from a therapeutic effect. However, in my opinion there is no reason today not to do an easy LND in all RCC patients who could have microscopic nodal disease and not only in high-risk patients. This means LND should be performed in all patients at risk and certainly in the actually selected RN candidates.

Keywords

Stratification Technetium 

References

  1. 1.
    Blom JH, Van Poppel H, Marechal JM, Jacqmin D, Schroder FH, de Prijck L, Sylvester R. Radical nephrectomy with and without lymph-node dissection: final results of European organization for research and treatment of cancer (EORTC) randomized phase 3 trial 30881. Eur Urol. 2009;55(1):28–34.PubMedCrossRefGoogle Scholar
  2. 2.
    Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol. 2004;172(2): 465–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, Gitlitz BJ, Figlin RA, Belldegrun AS. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol. 2003;169(6): 2076–83.PubMedCrossRefGoogle Scholar
  4. 4.
    Delacroix Jr SE, Wood CG. The role of lymphadenectomy in renal cell carcinoma. Curr Opin Urol. 2009;19(5):465–72.PubMedCrossRefGoogle Scholar
  5. 5.
    Canfield SE, Kamat AM, Sanchez-Ortiz RF, Detry M, Swanson DA, Wood CG. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol. 2006;175(3 Pt 1):864–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Terrone C, Cracco C, Porpiglia F, Bollito E, Scoffone C, Poggio M, Berruti A, Ragni F, Cossu M, Scarpa RM, Rossetti SR. Reassessing the current TNM lymph node staging for renal cell carcinoma. Eur Urol. 2006;49(2):324–31.PubMedCrossRefGoogle Scholar
  7. 7.
    Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969;101(3):297–301.PubMedGoogle Scholar
  8. 8.
    Russo P, Jang TL, Pettus JA, Huang WC, Eggener SE, O’Brien MF, Karellas ME, Karanikolas NT, Kagiwada MA. Survival rates after resection for localized kidney cancer: 1989 to 2004. Cancer. 2008;113(1): 84–96.PubMedCrossRefGoogle Scholar
  9. 9.
    Parker A. Studies on the main posterior lymph channels of the abdomen and their connections with the lymphatics of the genitourinary system. Am J Anat. 1935;56:409.CrossRefGoogle Scholar
  10. 10.
    Assouad J, Riquet M, Foucault C, Hidden G, Delmas V. Renal lymphatic drainage and thoracic duct connections: implications for cancer spread. Lymphology. 2006;39(1):26–32.PubMedGoogle Scholar
  11. 11.
    Saitoh H, Nakayama M, Nakamura K, Satoh T. Distant metastasis of renal adenocarcinoma in nephrectomized cases. J Urol. 1982;127(6):1092–5.PubMedGoogle Scholar
  12. 12.
    Johnsen JA, Hellsten S. Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol. 1997;157(2):450–3.PubMedCrossRefGoogle Scholar
  13. 13.
    Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. J Urol. 2001;166(1): 68–72.PubMedCrossRefGoogle Scholar
  14. 14.
    Lughezzani G, Capitanio U, Jeldres C, Isbarn H, Shariat SF, Arjane P, Widmer H, Perrotte P, Montorsi F, Karakiewicz PI. Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective. Cancer. 2009;115(24):5680–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Crispen PL, Breau RH, Allmer C, Lohse CM, Cheville JC, Leibovich BC, Blute ML. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Eur Urol. 2011;59(1): 18–23.PubMedCrossRefGoogle Scholar
  16. 16.
    Wood Jr DP. Role of lymphadenectomy in renal cell carcinoma. Urol Clin North Am. 1991;18(3):421–6.PubMedGoogle Scholar
  17. 17.
    Herrlinger A, Schrott KM, Schott G, Sigel A. What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma. J Urol. 1991;146(5):1224–7.PubMedGoogle Scholar
  18. 18.
    Sobin LH, Wittekind C. TNM classification of malignant tumours. 5th ed. New York: Wiley; 1997. p. xxiii. 227 p.Google Scholar
  19. 19.
    Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002. p. xxiii. 239 p.Google Scholar
  20. 20.
    Terrone C, Guercio S, De Luca S, Poggio M, Castelli E, Scoffone C, Tarabuzzi R, Scarpa RM, Fontana D, Rocca Rossetti S. The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int. 2003;91(1):37–40.PubMedCrossRefGoogle Scholar
  21. 21.
    Schafhauser W, Ebert A, Brod J, Petsch S, Schrott KM. Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy. Anticancer Res. 1999;19(2C):1573–8.PubMedGoogle Scholar
  22. 22.
    Joslyn SA, Sirintrapun SJ, Konety BR. Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the national surveillance, epidemiology, and end results database. Urology. 2005;65(4):675–80.PubMedCrossRefGoogle Scholar
  23. 23.
    Margulis V, Wood CG. The role of lymph node dissection in renal cell carcinoma: the pendulum swings back. Cancer J. 2008;14(5):308–14.PubMedCrossRefGoogle Scholar
  24. 24.
    Godoy G, O’Malley RL, Taneja SS. Lymph node dissection during the surgical treatment of renal cancer in the modern era. Int Braz J Urol. 2008;34(2):132–42.PubMedCrossRefGoogle Scholar
  25. 25.
    Whitson JM, Harris CR, Reese AC, Meng MV. Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases. J Urol. 2011;185(5):1615–20.PubMedCrossRefGoogle Scholar
  26. 26.
    Simmons MN, Kaouk J, Gill IS, Fergany A. Laparoscopic radical nephrectomy with hilar lymph node dissection in patients with advanced renal cell carcinoma. Urology. 2007;70(1):43–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Chapman TN, Sharma S, Zhang S, Wong MK, Kim HL. Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma. Urology. 2008;71(2): 287–91.PubMedCrossRefGoogle Scholar
  28. 28.
    Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D. AJCC cancer staging manual. 6th ed. Philadelphia: Lippincott-Raven; 2002.Google Scholar
  29. 29.
    Dimashkieh HH, Lohse CM, Blute ML, Kwon ED, Leibovich BC, Cheville JC. Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma. J Urol. 2006;176(5): 1978–82.PubMedCrossRefGoogle Scholar
  30. 30.
    Kwon T, Song C, Hong JH, Kim CS, Ahn H. Reassessment of renal cell carcinoma lymph node staging: analysis of patterns of progression. Urology. 2011;77(2):373–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Edge S. American joint committee on cancer. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.Google Scholar
  32. 32.
    Van Poppel H. Lymph node dissection is not obsolete in clinically node-negative renal cell carcinoma patients. Eur Urol. 2011;59(1):24–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Studer UE, Birkhauser FD. Lymphadenectomy combined with radical nephrectomy: to do or not to do? Eur Urol. 2009;55(1):35–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Studer UE, Scherz S, Scheidegger J, Kraft R, Sonntag R, Ackermann D, Zingg EJ. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol. 1990;144(2 Pt 1):243–5.PubMedGoogle Scholar
  35. 35.
    Giberti C, Oneto F, Martorana G, Rovida S, Carmignani G. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases. Eur Urol. 1997;31(1):40–8.PubMedGoogle Scholar
  36. 36.
    Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. J Urol. 2002;168(1):56–60.PubMedCrossRefGoogle Scholar
  37. 37.
    Skinner DG, Vermillion CD, Colvin RB. The surgical management of renal cell carcinoma. J Urol. 1972;107(5):705–10.PubMedGoogle Scholar
  38. 38.
    Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol. 2001;166(5):1611–23.PubMedCrossRefGoogle Scholar
  39. 39.
    Karakiewicz PI, Trinh QD, Bhojani N, Bensalah K, Salomon L, de la Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Schips L, Zigeuner R, Mulders PF, Valeri A, Descotes JL, Mejean A, Patard JJ. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol. 2007;51(6): 1616–24.PubMedCrossRefGoogle Scholar
  40. 40.
    Giuliani L, Giberti C, Martorana G, Rovida S. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol. 1990;143(3): 468–73.PubMedGoogle Scholar
  41. 41.
    Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, Gitlitz B, Belldegrun AS, Figlin RA. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. Cancer. 2003;97(12):2995–3002.PubMedCrossRefGoogle Scholar
  42. 42.
    Hutterer GC, Patard JJ, Perrotte P, Ionescu C, de La Taille A, Salomon L, Verhoest G, Tostain J, Cindolo L, Ficarra V, Artibani W, Schips L, Zigeuner R, Mulders PF, Valeri A, Chautard D, Descotes JL, Rambeaud JJ, Mejean A, Karakiewicz PI. Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram. Int J Cancer. 2007;121(11):2556–61.PubMedCrossRefGoogle Scholar
  43. 43.
    Ming X, Ningshu L, Hanzhong L, Zhongming H, Tonghua L. Value of frozen section analysis of enlarged lymph nodes during radical nephrectomy for renal cell carcinoma. Urology. 2009;74(2):364–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Bex A, Vermeeren L, de Windt G, Prevoo W, Horenblas S, Olmos RA. Feasibility of sentinel node detection in renal cell carcinoma: a pilot study. Eur J Nucl Med Mol Imaging. 2010;37(6):1117–23.PubMedCrossRefGoogle Scholar
  45. 45.
    Leibovich BC, Blute ML. Lymph node dissection in the management of renal cell carcinoma. Urol Clin North Am. 2008;35(4):673–8. viii.PubMedCrossRefGoogle Scholar
  46. 46.
    Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. J Urol. 2008;180(1): 99–103.PubMedCrossRefGoogle Scholar
  47. 47.
    Capitanio U, Becker F, Blute ML, Mulders P, Patard JJ, Russo P, Studer UE, Van Poppel H. Lymph node dissection in renal cell carcinoma. Eur Urol. 2011;60(6):1212–20.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of UrologyUniversity Hospital, K.U.LeuvenLeuvenBelgium

Personalised recommendations